Oklahoma’s Case Against Johnson & Johnson Moves into Defense Phase
Oklahoma’s case against J&J claiming the company was the “kingpin” in the opioid crisis moves into the defense phase.
Drugs & Medical Devices
New Study Finds Prescribers Contributed to Opioid Crisis
Surgeons may be contributing to the opioid crisis by overprescribing after procedures, according to new report.
Cardinal Health Fined for Violating Federal Opioid Guidelines
Cardinal Health allegedly did not report suspicious opioid orders to the DEA and has been fined $44 million.
Nurse is Charged with Stealing Opioids, Causing Cancer Patient Infections
Kelsey Mulvey, 27, used her position as a nurse to steal opioids meant for cancer patients.
Judge Says Settlement Must Comply with a New Legislative Arrangement
Judge says Oklahoma needs to prove that settlement funds from opioid litigation comply with a new state law.
Insys Therapeutics, Maker of Subsys, Files Chapter 11
Phoenix-based opioid manufacturer Insys Therapeutics has officially filed for Chapter 11 bankruptcy protection just five days after agreeing to pay $225 million to settle the litigation against it concerning the powerful fentanyl spray, Subsys. Insys asked the court to “allow it to sell its assets to pay more than $250 million in debts,” according to
Husel Turns Himself In, Charged with Twenty-Five Counts of Murder
Dr. William Husel turned himself in and is being charged with twenty-five counts of murder for prescribing high doses of fentanyl.
Connecticut’s Opioid Tax is Met with Opposition from Distributors
As Connecticut proposes opioid tax, distributors push back.
Oklahoma Faces Off with Johnson & Johnson in Opioid Trial
Oklahoma takes J & J to court in opioid trial. J & J mounts its defense.
Program Identifies Potential Opioid Abuse in the Workforce
The crippling opioid abuse crisis is decreasing employee productivity. One company is stepping in with resources to keep people at work.